Novartis Mulls Selling Underperforming Unit As Sales Decline Continues

Novartis Mulls Selling Underperforming Unit As Sales Decline Continues

Novartis stock jumped Tuesday after the company said it's considering selling or spinning off its underperforming generics business, Sandoz.